Menu
Recruiting NCT06967324

GRACE - Graduated Response for Advanced COPD With Enhanced Support

No phase Interventional COPD (Chronic Obstructive Pulmonary Disease)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Stepped care, Usual Care.
Who it may be relevant to
Registry conditions: COPD (Chronic Obstructive Pulmonary Disease). Basic parameters: from 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Denmark
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of this study is to explore the feasibility and potential for a positive impact of a graduated response for advanced COPD with Enhanced Support. The study is a randomized controlled trial of: * systematic needs assessment * advance care planning * crossectoral virtual conferences. Researchers will compare quality of life and healthcare use of the intervention group with a control group that will be assessed for intervention need at the last follow-up.

Detailed description

The current study is a non-blinded randomized controlled pilot trial. The control group will be offered treatment as usual whereas the intervention group will be allocated to the GRACE model of care. In total, 100 patients and their caregivers will be included. The patients are all community dwelling and attached to the Outpatient Respiratory Medicine Clinic at Hvidovre Hospital. The patients will be randomized by block randomization to intervention and control group with a ratio of 1:1. Furthermore, the patients will be stratified according to which municipality they belong to, to ensure we gather feasibility data from two municipalities. The control group will be offered to be assessed for their eligibility for palliative care through the existing visitation conference at the end of the trial period. Endpoints include: Patient-reported (quality of life, anxiety and depression, self-efficacy), caregiver-reported ( caregiver burden, anxiety and depression, well-being) and patient healthcare use.

Interventions

  • Other Stepped care
    Graduated palliative cross-sectoral care
  • Other Usual Care
    Usual care at the outpatient respiratory clinic

Primary outcome measures

  • ICECAP-SCM [Time frame: 6 months]
Secondary outcome measures (12)
  • ICECAP-SCM [Time frame: 3 months]
  • ICECAP-SCM [Time frame: 9 months]
  • ICECAP-SCM [Time frame: 12 months]
  • HADS [Time frame: 3]
  • HADS [Time frame: 6]
  • HADS [Time frame: 9 months]
  • HADS [Time frame: 12 months]
  • GSE [Time frame: 3 months]
  • GSE [Time frame: 6 months]
  • GSE [Time frame: 9 months]
  • GSE [Time frame: 12 months]
  • Hospital admissions [Time frame: 3 months]

Eligibility criteria

Inclusion criteria

  • COPD
  • Exacerbation within the last year
  • Living in Høje Taastrup or Copenhagen
  • Cognitively relevant
  • ICECAP-SCM at least two scores of:
  • 1, 2
  • 1, 2
  • 1, 2
  • 1, 2
  • 1, 2, 3
  • 1, 2
  • 1, 2

Exclusion criteria

  • Dementia
  • Psychosis
  • Substance abuse
  • Hearing or speech impairment
  • Cancer
  • Receiving specialized palliative care or other similar interventions
  • Immediately dying

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Supportive care

Study locations

Denmark · 1 center
  • Copenhagen University Hospital - Hvidovre — Hvidovre

Identifiers

NCT: NCT06967324 · H-25009646

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗